Question

I am a breastfeeding mother and i want to know if it is safe to use HSDB 3002? Is HSDB 3002 safe for nursing mother and child? Does HSDB 3002 extracts into breast milk? Does HSDB 3002 has any long term or short term side effects on infants? Can HSDB 3002 influence milk supply or can HSDB 3002 decrease milk supply in lactating mothers?

HSDB 3002 lactation summary

HSDB 3002 is safe in breastfeeding
  • DrLact safety Score for HSDB 3002 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of HSDB 3002 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that HSDB 3002 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of HSDB 3002 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About HSDB 3002 usage in lactation

Carbonic anhydrase inhibitor diuretic that has been used in the treatment of glaucoma, intracraneal hypertension and some types of epilepsy. Small amonut presented in the breast milk does not have any effect on the nursing baby. American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding.

Answer by DrLact: About HSDB 3002 usage in lactation

Limited information indicates that maternal doses of HSDB 3002 up to 1000 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants.

HSDB 3002 Side Effects in Breastfeeding

A breastfed (extent not stated) infant whose mother was taking sustained-release HSDB 3002 (Diamox Sequels) 500 mg twice daily exhibited no apparent adverse effects related to HSDB 3002 from day 6 to day 10 postpartum.[1] A mother who was taking HSDB 3002 250 mg orally twice daily as well as using 2 drops of timolol 0.5% eye drops daily and pilocarpine eye drops twice daily delivered a preterm infant at 36 weeks of gestation. The infant began 5 months of exclusive breastfeeding at 6 hours after birth. On day 2, the infant developed electrolyte abnormalities consisting of hypocalcemia, hypomagnesemia, and metabolic acidosis. The infant was treated with oral calcium gluconate and a single dose of intramuscular magnesium sulfate. Despite continued breastfeeding and maternal drug therapy, the infant's mild metabolic acidosis disappeared on day 4 of life and the infant was gaining weight normally at 1, 3 and 8 months, but had mild hypotonicity. The authors considered the metabolic effects to be caused by transplacental passage of HSDB 3002 that resolved despite the infant being breastfed. The infant gained weight adequately during breastfeeding, but had some mild, residual hypertonicity of the lower limbs requiring physical therapy.[2]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.